La vendita allo scoperto per MGP Ingredients dà agli investitori un'idea del grado in cui gli investitori stanno scommettendo sul declino delle azioni di MGP Ingredients. I dati relativi alle vendite allo scoperto vengono aggiornati ogni due settimane.

MGP Ingredients (NASDAQ:MGPI) Azioni, Report sulle vendite allo scoperto

MGP Ingredients

MGP Ingredients Inc is a producer and supplier of premium distilled spirits and specialty wheat protein and starch food ingredients. MGP also produces high-quality industrial alcohol for use in both food and non-food applications. It operates in three segments: Distillery Solutions, Branded Spirits Segment, and Ingredient Solutions. Distillery Solutions provides distillery co-products, such as distillers feed, fuel grade alcohol, and corn oil: and warehouse services, including barrel put away, storage, and retrieval services. It derives most of its revenue from the Distillery Solutions segment.

MGP Ingredients Inc

TD Cowen analyst Robert Moskow downgrades MGP Ingredients (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MGPI#NASDAQ">MGPI</a>) from Buy to Hold and lowers the price target from $66 to $50.

News

Downgrades

Price Target

Analyst Ratings

MGPI

TD Cowen Downgrades MGP Ingredients to Hold, Lowers Price Target to $50

Roth MKM analyst Sean McGowan maintains MGP Ingredients (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MGPI#NASDAQ">MGPI</a>) with a Buy and lowers the price target from $69 to $65.

Roth MKM Maintains Buy on MGP Ingredients, Lowers Price Target to $65

Truist Securities analyst Bill Chappell maintains MGP Ingredients (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MGPI#NASDAQ">MGPI</a>) with a Buy and lowers the price target from $85 to $75.

Truist Securities Maintains Buy on MGP Ingredients, Lowers Price Target to $75

WIIM

MGP Ingredients shares are trading lower after the company reported mixed Q3 financial results and cut its FY24 guidance.

Guidance

MGP Ingredients Lowers FY24 Outlook: Sees Sales Of $695M-$705M Vs. $699.26M Estimate (Prior View: $742M-$756M); Projects Adjusted EPS Of  $5.55-$5.65 Vs. $5.57 Estimate (Prior View: $6.12-$6.23)

MGP Ingredients (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MGPI#NASDAQ">MGPI</a>) reported quarterly earnings of $1.29 per share which beat the analyst consensus estimate of $1.25 by 3.2 percent. The company reported quarterly sales of $161.461 million which missed the analyst consensus estimate of $161.551 million by 0.06 percent. This is a 23.70 percent decrease over sales of $211.624 million the same period last year.

Earnings

Earnings Beats

Earnings Misses

MGP Ingredients Q3 2024 Adj. EPS $1.29 Beats $1.25 Estimate, Sales $161.461M Miss $161.551M Estimate

Truist Securities analyst Bill Chappell maintains MGP Ingredients (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MGPI#NASDAQ">MGPI</a>) with a Buy and lowers the price target from $95 to $85.

Truist Securities Maintains Buy on MGP Ingredients, Lowers Price Target to $85

U.S. stocks traded mostly higher toward the end of trading, with the Nasdaq Composite gaining over 100 points on Friday.
The Dow traded up 0.04% to 43,258.31 while the NASDAQ rose 0.67% to 18,496.61. The S&amp;P 500 also rose, gaining, 0.40% to 5,865.01.
Check This Out: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/10/41377157/top-3-risk-off-stocks-which-could-rescue-your-portfolio-this-quarter">Top 3 Risk Off Stocks Which Could Rescue Your Portfolio This Quarter</a>
Leading and Lagging Sectors Communication services shares jumped by 1% on Friday.
In trading on Friday, energy shares fell by 0.5%.
Top Headline
Schlumberger N.V. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SLB#NYSE">SLB</a>) reported mixed third-quarter results.
Revenue grew 10.2% year over year to $9.159 billion, missing the consensus of $9.25 billion. Adjusted EPS increased 14% to 89 cents, above the consensus of 88 cents.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>United States Cellular Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/USM#NYSE">USM</a>) shares shot up 7% to $62.56 after the company announced the sale of a portion of its retained spectrum licenses to Verizon for $1 billion.</li>
<li>Shares of Bright Minds Biosciences Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DRUG#NASDAQ">DRUG</a>) got a boost, surging 159% to $56.25. The company announced a $35 million non-brokered private placement.</li>
<li>SOBR Safe, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOBR#NASDAQ">SOBR</a>) shares were also up, gaining 27% to $10.10 after the company announced it filed a form RW and will not pursue a public offering at this time.</li>
</ul>
Equities Trading DOWN
<ul>
<li>MGP Ingredients, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MGPI#NASDAQ">MGPI</a>) shares dropped 25% to $60.96 after the company issued soft preliminary guidance and lowered its 2024 financial outlook.</li>
<li>Shares of Lilium N.V. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LILM#NASDAQ">LILM</a>) were down 15% to $0.4917. On Thursday, Canaccord Genuity downgraded the stock from Buy to Hold and cut its price target from $1.85 to $0.70.</li>
<li>CVS Health Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVS#NYSE">CVS</a>) was down, falling 6% to $59.83 after the company cut its third-quarter outlook.</li>
</ul>
Commodities In commodity news, oil traded down 1.5% to $69.62 while gold traded up 0.9% at $2,731.20.
Silver traded up 4.9% to $33.325 on Friday, while copper rose 1.5% to $4.3880.
Euro zone
European shares closed mostly higher today. The eurozone's STOXX 600 rose 0.21%, Germany's DAX rose 0.38% and France's CAC 40 climbed 0.39%. Spain's IBEX 35 Index rose 0.17%, while London's FTSE 100 fell 0.32%.
Construction output in the Eurozone fell by 2.5% year-over-year in August compared to a revised 2.3% decline in the previous month. The current account surplus in the Eurozone increased to €35.2 billion in August from €26.8 billion in the year-ago period.
Asia Pacific Markets
Asian markets closed higher on Friday, with Japan's Nikkei 225 gaining 0.18%, Hong Kong's Hang Seng Index climbing 3.61%, China's Shanghai Composite Index gaining 2.91% and India's BSE Sensex gaining 0.27%.
Economics
<ul>
<li>U.S. housing starts fell by 0.5% from the previous month to an annualized rate of 1.354 million units in September.</li>
<li>Building permits declined by 2.9% to an annual rate of 1.428 million in September.</li>
<li>The total number of active U.S. oil rigs rose by one to 482 rigs this week, Baker Hughes Inc reported.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/10/41402086/wall-streets-most-accurate-analysts-give-their-take-on-3-financials-stocks-delivering-hi">Wall Street&#8217;s Most Accurate Analysts Give Their Take On 3 Financials Stocks Delivering High-Dividend Yields</a></li>
</ul>

DRUG

LILM

SOBR

Nasdaq Surges Over 100 Points; Schlumberger Reports Mixed Q3 Result

U.S. stocks traded mostly higher midway through trading, with the Nasdaq Composite gaining around 100 points on Friday.
The Dow traded up 0.03% to 43,252.87 while the NASDAQ rose 0.55% to 18,474.05. The S&amp;P 500 also rose, gaining, 0.33% to 5,861.03.
Check This Out: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/10/41377157/top-3-risk-off-stocks-which-could-rescue-your-portfolio-this-quarter">Top 3 Risk Off Stocks Which Could Rescue Your Portfolio This Quarter</a>
Leading and Lagging Sectors Communication services shares jumped by 1.2% on Friday.
In trading on Friday, energy shares fell by 1%.
Top Headline
American Express Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AXP#NYSE">AXP</a>) shares fell around 5% on Friday after the company reported results for the third quarter.
The company said quarterly revenue (net of interest expense) grew 8% year-on-year to $16.64 billion, marginally missing the analyst consensus estimate of $16.67 billion. Adjusted EPS of $3.49 beat the analyst consensus estimate of $3.28.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>United States Cellular Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/USM#NYSE">USM</a>) shares shot up 12% to $65.62 after the company announced the sale of a portion of its retained spectrum licenses to Verizon for $1 billion.</li>
<li>Shares of Bright Minds Biosciences Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DRUG#NASDAQ">DRUG</a>) got a boost, surging 196% to $64.35. The company announced a $35 million non-brokered private placement.</li>
<li>SOBR Safe, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOBR#NASDAQ">SOBR</a>) shares were also up, gaining 55% to $12.30 after the company announced it filed a form RW and will not pursue a public offering at this time.</li>
</ul>
<h3 class="wp-block-heading">Equities Trading DOWN</h3>
<ul>
<li>MGP Ingredients, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MGPI#NASDAQ">MGPI</a>) shares dropped 26% to $60.24 after the company issued soft preliminary guidance and lowered its 2024 financial outlook.</li>
<li>Shares of Lilium N.V. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LILM#NASDAQ">LILM</a>) were down 11% to $0.5101. On Thursday, Canaccord Genuity downgraded the stock from Buy to Hold and cut its price target from $1.85 to $0.70.</li>
<li>CVS Health Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVS#NYSE">CVS</a>) was down, falling 8% to $58.77 after the company cut its third-quarter outlook.</li>
</ul>
Commodities In commodity news, oil traded down 1.2% to $69.84 while gold traded up 0.9% at $2,731.90.
Silver traded up 2.9% to $32.705 on Friday, while copper rose 1.2% to $4.3785.
Euro zone
European shares were mixed today. The eurozone's STOXX 600 rose 0.1%, Germany's DAX rose 0.31% and France's CAC 40 climbed 0.35%. Spain's IBEX 35 Index fell 0.1%, while London's FTSE 100 fell 0.52%.
Construction output in the Eurozone fell by 2.5% year-over-year in August compared to a revised 2.3% decline in the previous month. The current account surplus in the Eurozone increased to €35.2 billion in August from €26.8 billion in the year-ago period.
Asia Pacific Markets
Asian markets closed higher on Friday, with Japan's Nikkei 225 gaining 0.18%, Hong Kong's Hang Seng Index climbing 3.61%, China's Shanghai Composite Index gaining 2.91% and India's BSE Sensex gaining 0.27%.
Economics
<ul>
<li>U.S. housing starts fell by 0.5% from the previous month to an annualized rate of 1.354 million units in September.</li>
<li>Building permits declined by 2.9% to an annual rate of 1.428 million in September.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/10/41402086/wall-streets-most-accurate-analysts-give-their-take-on-3-financials-stocks-delivering-hi">Wall Street&#8217;s Most Accurate Analysts Give Their Take On 3 Financials Stocks Delivering High-Dividend Yields</a></li>
</ul>

Equities

Eurozone

Commodities

Intraday Update

Markets

Trading Ideas

Crude Oil Down Over 1%; American Express Shares Fall After Q3 Results

Roth MKM analyst Sean McGowan maintains MGP Ingredients (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MGPI#NASDAQ">MGPI</a>) with a Buy and lowers the price target from $92 to $88.

Roth MKM Maintains Buy on MGP Ingredients, Lowers Price Target to $88

Lake Street analyst Ben Klieve downgrades MGP Ingredients (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MGPI#NASDAQ">MGPI</a>) from Buy to Hold and announces $75 price target.

Lake Street Downgrades MGP Ingredients to Hold, Announces $75 Price Target

U.S. stock futures were mixed this morning, with the Nasdaq futures gaining around 90 points on Friday.
Shares of CVS Health Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVS#NYSE">CVS</a>) fell sharply in today's pre-market trading after the company cut its <a href="https://www.benzinga.com/quote/CVS">third-quarter outlook.</a>
CVS Health appointed longtime executive David Joyner as its new president and CEO, replacing Karen Lynch amid the company's ongoing financial struggles. The company warned that its upcoming third-quarter earnings, set for release on November 6, will miss Wall Street projections.
CVS Health shares dipped 11.6% to $56.29 in pre-market trading.
Here are some big stocks recording losses in today's pre-market trading session.
<ul>
<li>MGP Ingredients, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MGPI#NASDAQ">MGPI</a>) shares dipped 16.6% to $68.06 after the company issued soft preliminary guidance and lowered its 2024 financial outlook.</li>
<li>Coherent Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COHR#NASDAQ">COHR</a>) shares fell 4.6% to $97.39 in pre-market trading.</li>
<li>Zeta Global Holdings Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZETA#NYSE">ZETA</a>) shares fell 4.5% to $28.66 in pre-market trading. Zeta is expected to release its third quarter 2024 financial results after the closing bell on Monday, Nov. 11.</li>
<li>Jin Medical International Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZJYL#NASDAQ">ZJYL</a>) shares fell 4.3% to $2.03 in pre-market trading after declining around 5% on Thursday.</li>
<li>GrafTech International Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EAF#NASDAQ">EAF</a>) shares fell 4.1% to $1.62 in pre-market trading.</li>
<li>Gevo, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GEVO#NASDAQ">GEVO</a>) shares fell 3.8% to $2.55 in pre-market trading. HC Wainwright &amp; Co. analyst Amit Dayal reiterated Gevo with a Buy and maintained a $14 price target.</li>
<li>American Express Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AXP#NYSE">AXP</a>) shares fell 3.6% to $275.50 in pre-market trading following third-quarter results.</li>
<li>Fresh Del Monte Produce Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FDP#NYSE">FDP</a>) shares fell 3.5% to $29.00 in pre-market trading. Fresh Del Monte Produce will issue a press release on its third quarter financial results prior to market opening on Thursday, Oct. 31.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/markets/24/10/41390636/top-2-real-estate-stocks-that-may-fall-off-a-cliff-in-q4">Top 2 Real Estate Stocks That May Fall Off A Cliff In Q4</a></li>
</ul>

Pre-Market Outlook

COHR

GEVO

ZETA

ZJYL

CVS Health Cuts Outlook, Joins American Express And Other Big Stocks Moving Lower In Friday's Pre-Market Session

MGP Ingredients shares are trading lower after the company issued soft preliminary guidance and lowered its 2024 financial outlook.

Shares of Intuitive Surgical, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>) rose sharply in today's pre-market trading as the company posted better-than-expected <a href="https://www.benzinga.com/news/earnings/24/10/41391471/intuitive-surgical-stock-pops-on-q3-earnings-beat-da-vinci-procedures-climb-18-regulatory-clearance">third-quarter financial results</a>.
The company also said it obtained regulatory clearance in South Korea for the da Vinci 5 surgical system in October.
Intuitive Surgical shares jumped 6.9% to $506.38 in the pre-market trading session.
Here are some other stocks moving in pre-market trading.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>SOBR Safe, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOBR#NASDAQ">SOBR</a>) rose 95.2% to $15.52 in pre-market trading after the company announced it filed a form RW and will not pursue a public offering at this time.</li>
<li>JIADE Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JDZG#NASDAQ">JDZG</a>) gained 62.9% to $2.77 in pre-market trading after jumping around 136% on Thursday.</li>
<li>Catheter Precision, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VTAK#NASDAQ">VTAK</a>) shares surged 39.8% to $0.6160 in pre-market trading.</li>
<li>Akanda Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AKAN#NASDAQ">AKAN</a>) gained 34% to $1.30 in pre-market trading.</li>
<li>Tenon Medical, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TNON#NASDAQ">TNON</a>) rose 33.2% to $4.57 in pre-market trading. Tenon Medical(R) announced issuance of three U.S. patents.</li>
<li>Pineapple Energy Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PEGY#NASDAQ">PEGY</a>) shares jumped 24.7% to $6.87 in pre-market trading after gaining around 9% on Thursday.</li>
<li>cbdMD, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YCBD#NASDAQ">YCBD</a>) shares rose 18.6% to $0.51 in pre-market trading.</li>
<li>Jet.AI Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JTAI#NASDAQ">JTAI</a>) climbed 13.6% to $0.1101 in pre-market trading after jumping over 12% on Thursday.</li>
<li>Netflix, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFLX#NASDAQ">NFLX</a>) gained 5.8% to $727.17 in pre-market trading after the company reported stronger-than-expected third-quarter financial results.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>Orgenesis Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ORGS#NASDAQ">ORGS</a>) shares dipped 48.3% to $1.65 in pre-market trading after declining around 4% on Thursday.</li>
<li>NuZee, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NUZE#NASDAQ">NUZE</a>) shares fell 38.7% to $1.41 in pre-market trading after jumping 546% on Thursday. The company announced it moved its U.S. operations from California to Florida in order to develop its global business.</li>
<li>Molecular Templates, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTEM#NASDAQ">MTEM</a>) fell 38.7% to $0.57 in today's pre-market trading amid volatility after the company recently announced it approved the liquidation and wind-up.</li>
<li>NKGen Biotech, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NKGN#NASDAQ">NKGN</a>) fell 36.4% to $0.4455 in pre-market trading after jumping 154% on Thursday.</li>
<li>Olema Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OLMA#NASDAQ">OLMA</a>) shares declined 18.8% to $10.00 in pre-market trading.</li>
<li>Staffing 360 Solutions, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STAF#NASDAQ">STAF</a>) declined 18.4% to $1.89 in pre-market trading after jumping 68% on Thursday.</li>
<li>MGP Ingredients, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MGPI#NASDAQ">MGPI</a>) shares fell 16.6% to $68.06 after the company issued soft preliminary guidance and lowered its 2024 financial outlook.</li>
<li>VS MEDIA Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VSME#NASDAQ">VSME</a>) shares declined 16.4% to $1.88 in pre-market trading.</li>
<li>Cemtrex, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CETX#NASDAQ">CETX</a>) shares fell 15.8% to $0.3453 in pre-market trading after declining 10% on Thursday.</li>
<li>Notable Labs, Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTBL#NASDAQ">NTBL</a>) fell 14.5% to $0.3250 in pre-market trading after surging 57% on Thursday.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/10/41379749/abbvie-is-doing-very-well-but-jim-cramers-favorite-abbott-laboratories">AbbVie Is Doing &#8216;Very Well&#8217; But Jim Cramer&#8217;s Favorite? Abbott Laboratories</a></li>
</ul>

Movers

AKAN

CETX

ISRG

JDZG

JTAI

MTEM

NFLX

NKGN

NTBL

NUZE

OLMA

ORGS

PEGY

STAF

TNON

VSME

VTAK

YCBD

Why Intuitive Surgical Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket

MGP Ingredients Lowers FY24 Adj. EPS Guidance From $6.12-$6.23 To $5.55-$5.65 vs $6.24 Est., Lowers Sales Guidance From $742M-$756M To $695M-$705M vs $755.251M

MGP Ingredients Expects Q3 Sales To Decline 24% To $161.5M vs $185.286M Est., Distilling Solution Segment Sales Expected To Decline 36%; Sees Adj. EPS $1.29 vs $1.44 Est.

Truist Securities analyst Bill Chappell maintains MGP Ingredients (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MGPI#NASDAQ">MGPI</a>) with a Buy and lowers the price target from $125 to $95.

Truist Securities Maintains Buy on MGP Ingredients, Lowers Price Target to $95

MGP Ingredients Sees FY24 Sales $742M-$756M Vs $755.868M Est.; Adj. EPS $6.12-$6.23 Vs $6.17 Est.

MGP Ingredients (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MGPI#NASDAQ">MGPI</a>) reported quarterly earnings of $1.71 per share which beat the analyst consensus estimate of $1.54 by 11.04 percent. The company reported quarterly sales of $190.805 million which beat the analyst consensus estimate of $189.056 million by 0.93 percent. This is a 8.71 percent decrease over sales of $209.001 million the same period last year.

MGP Ingredients Q2 2024 Adj. EPS $1.71 Beats $1.54 Estimate, Sales $190.805M Beat $189.056M Estimate

Catalyst Watch: Eyes on tech with Apple, Amazon, Alphabet, and Meta reporting

Lake Street analyst Ben Klieve maintained a Hold rating on MGP Ingredients (MGPI – Research Report) today and set a price target of $75.00. The com...

Lake Street Reaffirms Their Hold Rating on MGP Ingredients (MGPI)

MGP Ingredients Non-GAAP EPS of $1.29 beats by $0.06, revenue of $161.46M in-line

MGP Ingredients, Inc. (MGPI) Q3 2024 Earnings Call Transcript

Wells Fargo analyst Marc Torrente maintained a Buy rating on MGP Ingredients (MGPI – Research Report) today and set a price target of $58.00. The c...

Wells Fargo Remains a Buy on MGP Ingredients (MGPI)

Roth MKM analyst Sean McGowan lowered the firm's price target on MGP Ingredients (MGPI) to $65 from $69 and keeps a Buy rating on the shares after ...

MGP Ingredients price target lowered to $65 from $69 at Roth MKM

In a report released yesterday, Bill Chappell from Truist Financial maintained a Buy rating on MGP Ingredients (MGPI – Research Report), with a pri...

Truist Financial Sticks to Their Buy Rating for MGP Ingredients (MGPI)

TD Cowen analyst Robert Moskow downgraded the rating on MGP Ingredients (MGPI – Research Report) to a Hold today, setting a price target of $50.00....

Hold Rating on MGP Ingredients Amid Supply-Demand Imbalance and Strategic Transition Challenges

TD Cowen analyst Robert Moskow downgraded MGP Ingredients (MGPI) to Hold from Buy with a price target of $50, down from $66. The firm believes the ...

MGP Ingredients downgraded to Hold from Buy at TD Cowen

Soft spirits: Brown-Forman slides on concerns about the slow recovery in demand

AAPL

AMZN

BMEA

CHTR

DASH

DVCMY

DVDCF

FFIV

FVRR

GOOG

HSBC

IDCC

INTC

INUV

LFVN

LMND

MRNS

MSFT

OSTX

PAPL

PDRDF

PHUN

PRNDY

PTON

QRVO

RDDT

REMYF

REMYY

RKLB

RMLFF

SABR

SAVE

SBUX

SNAP

SVCO

TLTFF

UBER

WHLR

XPEV

Legal

Press Releases

MGP ALERT: Bragar Eagel & Squire, P.C. is Investigating MGP Ingredients, Inc. on Behalf of MGP Stockholders and Encourages Investors to Contact the Firm

NASDAQ: MGPI Investigation Reminder:  Kessler Topaz Meltzer & Check, LLP Encourages MGP Ingredients, Inc. (NASDAQ: MGPI) Investors with Significant Losses to Contact the Firm

NASDAQ: MGPI Investigation: Kessler Topaz Meltzer & Check, LLP Encourages MGP Ingredients, Inc. (NASDAQ: MGPI) Investors with Significant Losses to Contact the Firm

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of MGP Ingredients, Inc.  - MGPI

MGPI Investigation Notice:  Kessler Topaz Meltzer & Check, LLP Encourages MGP Ingredients, Inc. (NASDAQ: MGPI) Investors with Significant Losses to Contact the Firm

MGP Ingredients Declares $0.12 Quarterly Dividend

MGP Ingredients Reports Third Quarter 2024 Results

MGP Ingredients, Inc. Investigation: Kessler Topaz Meltzer & Check, LLP Encourages MGP Ingredients, Inc. (NASDAQ: MGPI) Investors with Significant Losses to Contact the Firm

Scott+Scott Attorneys at Law LLP Alerts Investors of Its Investigation into MGP Ingredients, Inc. (NYSE: MGPI)

Comments

MGP Ingredients

Vendite allo scoperto

MGP Ingredients (NASDAQ:MGPI) Azioni, Report sulle vendite allo scoperto

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO